- Correction
- Open access
- Published:
Correction: Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
Microbiome volume 12, Article number: 111 (2024)
The Original Article was published on 31 January 2021
Correction: Microbiome 9, 34 (2021)
https://doi.org/10.1186/s40168-020-00988-6
Following publication of the original article [1], it was reported that the Supplementary Material did not include the Supplementary Figures. The correct Supplementary file is included here and the original article has been updated.
Reference
Hou Yf, Shan C, Zhuang Sy, et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease. Microbiome. 2021;9:34. https://doi.org/10.1186/s40168-020-00988-6.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Jian-min Liu is the lead contact.
Supplementary Information
40168_2024_1846_MOESM1_ESM.pdf
Additional file 1: Supplemental Table S1. The comparison of the behavioral tests in 6-OHDA-induced PD mice after the administration of OCN. Supplemental Table S2. The comparison of the behavioral tests in 6-OHDA-induced PD mice treated with OCN after gut microbiota-depletion. Supplemental Table S3. The comparison of the behavioral tests after fecal microbiota transplantation. Supplemental Table S4. The overall OTU numbers and annotation levels. Supplemental Table S5. The comparison of taxonomy RAs of gut microbiota in 6-OHDA-induced mice after the administration of OCN. Supplemental Table S6. The comparison of RAs of KOs regulating SCFA metabolism in 6-OHDA-induced mice after the administration of OCN. Supplemental Table S7. The comparison of the behavioral tests in 6-OHDA-induced mice after the administration of propionate. Supplemental Table S8. The comparison of the behavioral tests in 6-OHDA-induced mice after the administration of FFAR3 agonist. Supplemental Figure 1. OCN administration had no effect on motor function, dopaminergic neurons, gut microbiota and SCFAs. Supplemental Figure 2. Antibiotic treatment depleted the gut microbiota. Supplemental Figure 3. The comparison of alpha diversity of gut microbiota in 6-OHDA-induced PD mice. Supplemental Figure 4. Cisplatin ablated the enteric neurons. Supplemental Figure 5. Correlation analysis between the altered KO and gut microbial taxa.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hou, Yf., Shan, C., Zhuang, Sy. et al. Correction: Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease. Microbiome 12, 111 (2024). https://doi.org/10.1186/s40168-024-01846-5
Published:
DOI: https://doi.org/10.1186/s40168-024-01846-5